Efficacy and safety of erenumab in women with a history of menstrual migraine
Abstract Background We performed a post hoc, subgroup analysis of a phase 3, randomized, double-blind, placebo-controlled study of erenumab for prevention of episodic migraine (STRIVE) to determine the efficacy and safety of erenumab in women with self-reported menstrual migraine. Methods Patients r...
Main Authors: | Jelena M. Pavlovic, Koen Paemeleire, Hartmut Göbel, Jo Bonner, Alan Rapoport, Risa Kagan, Feng Zhang, Hernan Picard, Daniel D. Mikol |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | The Journal of Headache and Pain |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s10194-020-01167-6 |
Similar Items
-
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials
by: Stewart J Tepper, et al.
Published: (2021-07-01) -
Early onset of efficacy with erenumab in patients with episodic and chronic migraine
by: Todd Schwedt, et al.
Published: (2018-10-01) -
Menstrual Migraine in Adolescents
by: J Gordon Millichap
Published: (2009-04-01) -
Menstrual Disorders and its Association with Migraine
by: Shahrzad Fakhraee, et al.
Published: (2020-02-01) -
Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series
by: Raffaele Ornello, et al.
Published: (2021-03-01)